高危股骨柄的中长期结局与无菌性失败原因
回顾性分析2609例使用Accolade TMZF股骨柄行初次全髋关节置换的患者,平均随访11.3年,累积生存率95.5%±0.1%,无菌性松动为最常见无菌性失败原因(33/2609,1.3%),较小股骨尺寸和较大股骨头偏移为独立危险因素。
要点
- Accolade TMZF股骨柄累积生存率95.5%±0.1%,平均随访11.3年。
- 无菌性松动是最常见无菌性失败原因,33/2609例(1.3%)。
- 较小股骨尺寸和较大股骨头偏移为无菌性失败的独立危险因素。
核心结论
- 尽管早期存在担忧,Accolade TMZF股骨柄在该队列中具有 excellent 生存率。
- 因组配头颈腐蚀(trunnionosis)行翻修手术罕见。
研究设计与样本
- 回顾性综述在高容量关节置换中心接受Accolade TMZF股骨柄初次全髋关节置换的所有患者记录。
- 连续纳入2609例接受单侧初次全髋关节置换并使用Accolade TMZF股骨柄的患者。
- 采用Kaplan-Meier曲线进行生存分析,采用Cox比例风险模型分析患者和植入物因素。
主要发现
- 平均距初次手术时间为11.3年(范围0天至19.4年)。
- 末次随访时累积生存率为95.5%±0.1%。
- 107例患者接受翻修手术,股骨组件无菌性松动为最常见无菌性失败原因(33/2609;1.3%)。
- 较小股骨尺寸和较大股骨头偏移为无菌性失败的独立危险因素。
关键数值与推荐
- 无菌性松动为最常见无菌性失败原因,33/2609例(1.3%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 证据等级为治疗性IV级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Accolade TMZF is a tapered-wedge cementless metaphyseal-coated femoral stem that was widely utilized from 2002 to 2012. In recent years, there have been reports of early catastrophic failure of this implant. The purposes of the present study were to establish the long-term survival of this stem and to analyze patients who underwent aseptic revision to understand the causes and risk factors for failure. METHODS: We retrospectively reviewed the records of all patients who had undergone primary total hip arthroplasty with use of an Accolade TMZF stem at a high-volume arthroplasty center. The causes and timing of revision surgery were documented. Survivorship analysis was performed with use of Kaplan-Meier curves to determine the overall and aseptic survival rates at the time of the latest follow-up. Patient and implant factors commonly associated with aseptic failure were extracted, and a Cox proportional hazards model was used. RESULTS: A consecutive series of 2,609 patients who had undergone unilateral primary total hip arthroplasty with use of an Accolade TMZF femoral stem were included. The mean time from the primary procedure was 11.3 years (range, 0 days to 19.4 years). The cumulative survival rate was 95.5% ± 0.1% at the time of the latest follow-up. One hundred and seven patients underwent revision surgery, with aseptic loosening of the femoral component being the most common cause of aseptic failure in this cohort (33 of 2,609; 1.3%). Smaller femoral size and larger femoral head offset were independent risk factors for aseptic failure. CONCLUSIONS: To our knowledge, this is the largest series representing the longest follow-up of this tapered-wedge cementless femoral implant. Despite early concerns, the Accolade TMZF stem had excellent survivorship in this cohort. Trunnionosis as the cause for revision surgery was rare. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Gazendam A, Ekhtiari S, Wood TJ, et al. Intermediate to Long-Term Outcomes and Causes of Aseptic Failure of an At-Risk Femoral Stem. J Bone Joint Surg Am. 2022. PMID: 35188899. doi:10.2106/JBJS.21.00397
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。